Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Melanoma

Melanoma is a type of skin cancer that develops from cells called melanocytes. It’s the 5th most common cancer in the UK, with around 16,200 new cases of melanoma in the UK each year.
Showing 12 out of 123 results
The sun shining in a blue sky

New analysis shows that melanoma skin cancer rates in the UK have increased by almost a third over the past decade New analysis shows that melanoma skin cancer rates in the UK have increased by almost a third over the past decade

by Amy Warnock | News | 27 May 2024

27 May 2024

Vaccine vial and needle

Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, reflects on today's news that Moderna and MSD’s melanoma cancer vaccine is moving to Phase 3 clinical trials Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, reflects on today's news that Moderna and MSD’s melanoma cancer vaccine is moving to Phase 3 clinical trials

by Iain Foulkes | Opinion | 26 April 2024

26 April 2024

Two cancer researchers looking at a cell image on screen

Each cancer is as unique as the person it affects. By studying patient data, we can target our treatments to people's specific needs. Each cancer is as unique as the person it affects. By studying patient data, we can target our treatments to people's specific needs.

by Cancer Research UK | In depth | 21 November 2023

21 November 2023

Messages written in glow in the dark pen at a Shine night walk event to remember lost loved ones

Over two million years of life are lost to cancer in the UK every year, according to a new study from Cancer Research UK. However, the data also showed that thanks to innovation and research, we are making progress in beating cancer.   Over two million years of life are lost to cancer in the UK every year, according to a new study from Cancer Research UK. However, the data also showed that thanks to innovation and research, we are making progress in beating cancer.  

by Jacob Smith | News | 11 October 2023

11 October 2023

Melanoma skin cancer cases in the UK have reached an all-time high according to new analysis released today from Cancer Research UK. Melanoma skin cancer cases in the UK have reached an all-time high according to new analysis released today from Cancer Research UK.

by Sophie Wedekind | News | 7 July 2023

7 July 2023

An elderly male patient sat on a hospital bed

Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight.  Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight. 

by Jacob Smith | In depth | 29 May 2023

29 May 2023

Melanoma cells viewed under the microscope

New results from the Cancer Research UK-funded PEACE study have revealed how some skin cancers stop responding to treatment at the end of life. New results from the Cancer Research UK-funded PEACE study have revealed how some skin cancers stop responding to treatment at the end of life.

by Jacob Smith | News | 29 March 2023

29 March 2023

A photograph of a family walking their dog in the shade.

Skin cancer death rates in UK men have more than tripled since the early 1970s, according to new analysis released today by Cancer Research UK. Skin cancer death rates in UK men have more than tripled since the early 1970s, according to new analysis released today by Cancer Research UK.

by Lilly Matson | News | 15 July 2022

15 July 2022

Melanoma cell. Credit: Dr Erik Sahai

The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer. The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer.

by Harry Jenkins | News | 21 December 2021

21 December 2021